Author

Hanneke M. Straaten

Observed names: H M van der Straaten, Hanneke M van der Straaten, Hanneke M. Van Der Straaten, Hanneke M. Van der Straaten, Hanneke M. van der Straaten, Hanneke van der Straaten, Oudemans-van Straaten, H. M., Straaten, H.M. van der, van Straaten, H.M., van der Straaten, H.M.

Observed institutions: Utrecht University, University Medical Center Utrecht, St Clara Hospital

OpenAlex ID: A5071156978

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

2004 · Marijke R. Canninga-van Dijk, Hanneke M. van der Straaten, et al. · Blood · 129

PDF

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

2022 · Ingrid M Bistervels, Andrea Buchmüller, et al. · The Lancet · 119

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

2025 · Othman Al-Sawaf, Janina Stumpf, et al. · New England Journal of Medicine · 59

Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease

2006 · C Huisman, H M van der Straaten, et al. · Bone Marrow Transplantation · 46

PDF

Glycogen Storage Disease Type III

2009 · David J. Timson, Richard J. Reece, et al. · Springer eBooks · 41

Extra-Domain-A Fibronectin: A New Marker of Fibrosis in Cutaneous Graft-Versus-Host Disease

2004 · Hanneke M. van der Straaten, Marijke R. Canninga-van Dijk, et al. · Journal of Investigative Dermatology · 35

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial

2022 · Sabina Kersting, Julie Dubois, et al. · The Lancet Haematology · 31

PDF

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

2023 · Lina van der Straten, Claudia A. M. Stege, et al. · Blood · 29

PDF

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.

2005 · Hanneke M van der Straaten, Anja van Biezen, et al. · PubMed · 23

PDF

Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.

2005 · Flip H Jansen, Hanneke M van der Straaten, et al. · PubMed · 19

NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome after Nonmyeloablative Allogeneic Stem Cell Transplantation

2011 · Hanneke M. van der Straaten, Martine M. Paquay, et al. · Transplantation and Cellular Therapy · 12

Graft-Versus-Host Disease

2009 · Hanneke M. Van der Straaten, Leo F. Verdonck · Springer eBooks · 10

Relationship between graft‐versus‐host disease and graft‐versus‐leukaemia in partial T cell‐depleted bone marrow transplantation

2001 · Hanneke M. Van Der Straaten, Rob Fijnheer, et al. · British Journal of Haematology · 9

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia

2023 · Sabine Haggenburg, Hannah M. Garcia Garrido, et al. · Vaccines · 7

PDF

Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands

2017 · Sabina Kersting, Suzanne I.M. Neppelenbroek, et al. · Clinical Lymphoma Myeloma & Leukemia · 7

The FcγRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation

2005 · Hanneke M. van der Straaten, Rob Fijnheer, et al. · Transplantation and Cellular Therapy · 7

PDF

Hb Nouakchott [α114(GH2)Pro→Leu;HBA1: c.344C>T], A Second and Third Case Described in Two Unrelated Dutch Families

2018 · Kirsten M. Pondman, Jacoline W. Brinkman, et al. · Hemoglobin · 5

PDF

Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group

2022 · Doreen G. Te Raa, Lina van der Straten, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial

2016 · Kersting, S., Levin, M.D., et al. · Research Publications (Maastricht University) · 4

Glycogen Storage Disease Type I

2009 · David J. Timson, Richard J. Reece, et al. · Springer eBooks · 4

Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia: Results from the randomized CLL17 trial

2025 · Othman Al-Sawaf, Janina Stumpf, et al. · Blood · 3

PDF

Anticoagulants for ARDS: Facts and future

2014 · Cornet, A. D., Oudemans-van Straaten, H. M., et al. · Data Archiving and Networked Services (DANS) · 3

Glycine Encephalopathy

2009 · David J. Timson, Richard J. Reece, et al. · Springer eBooks · 2

Goitrous Autoimmune Thyroiditis

2009 · David J. Timson, Richard J. Reece, et al. · Springer eBooks · 2

Richtlijn 'Chronische Lymfatische Leukemie'

2016 · Stephan Kersting, M. van Gelder, et al. · Data Archiving and Networked Services (DANS) · 1

Works count: 142

Citation count: 616

H-index: 11

I10-index: 12